同时行抗压力性尿失禁手术在盆腔器官脱垂患者盆底重建手术中的有效性的Meta分析

目的:分析比较盆腔器官脱垂(POP)患者同时行盆底重建手术及抗压力性尿失禁手术和单纯行盆底重建手术的术后疗效。方法:计算机检索1999~2013年间Cochrane library、Embase、Medline等数据库。纳入符合条件的英文随机对照试验(RCT)文献,进行质量评估。运用Rev Man5.0软件进行Meta分析。结果:7个RCT文献纳入研究(n=642),经过Meta分析,单纯行盆底重建手术与盆底重建手术同时行抗压力性尿失禁手术相比,术后压力性尿失禁(RR=1.45,95%CI0.72~2.93,P=0.30)、急迫性尿失禁(RR=1.44,95%CI 0.73~2.84,P=0.29)、术后膀胱膨出(RR=1.30,95%CI 0.35~4.84,P=0.69)、术后性交困难(RR=1.20,95%CI 0.35~4.06,P=0.77)、术后再发POP(RR=0.87,95%CI 0.19~3.99,P=0.86)发生率和生活质量调查评分差异均无统计学意义。结论:和单纯盆底重建手术相比,同时行抗压力性尿失禁手术不能提高患者术后疗效,应妥善选择手术方式。     

网片对比传统阴道修补术治疗盆腔脏器脱垂的系统评价

目的本研究旨在系统评价网片（Mesh）治疗盆腔脏器脱垂与传统阴道修补术的有效性和安全性。方法计算机检索Cochrane Library、PubMed、EMBASE、中国生物医学文献数据库、中国期刊全文数据库、中文科技期刊全文数据库,检索时间截至2011年10月。检索词为pelvic organ prolapsed、POP、Mesh、盆腔脏器脱垂、网片等。纳入传统手术和网片对比治疗盆腔脏器脱垂的随机对照试验,由两名研究员分别独立提取数据和进行文献质量评价,并进行meta分析。结果共纳入5篇RCTs,meta分析结果显示：网片治疗妇女盆腔脏器脱垂并未增加手术成功率[RR=1.09,95%CI（0.58,2.02）,P=0.79]、降低术后POP-Q分度[MD=0.11,95%CI（-0.15,0.36）,P=0.41],同时术后性交困难[OR=1.25,95%CI（0.54,2.87）,P=0.60]和复发率[RR=0.76,95%CI（0.10,5.28）,P=0.78]等并未降低。结论当前证据表明：与传统手术相比,网片并不能增加手术的客观成功率,亦不能降低术后POP-Q分度以及术后感染等,尚需经济学评价及适用性研究以指导临床实践。     

新式阴道前壁补片修补术在女性压力性尿失禁中治疗效果评估

目的:探讨新式阴道前壁补片修补术术式的创新性及优、缺点,以及其对女性压力性尿失禁(SUI)的近期手术疗效。方法:对2009年1月至2012年2月我院收治的106例女性SUI患者行新式阴道前壁补片修补术。采用主观评价尿失禁问卷简表(ICIQ-SF)、客观评价尿垫试验等方法评价该术式的近期手术疗效。与经典文献Burch手术及TVT等术后1年治愈率比较,探讨此手术的创新性及优、缺点。观察患者的围手术期及术后并发症情况。结果:新式阴道前壁补片修补术术后1年,患者的治愈率为90.57%,ICIQ-SF评分明显降低(P0.001)。与Burch手术、TVT等术后1年的治愈率比较,无显著差异(P0.05)。患者围手术期的尿路感染、排尿不尽等并发症的发生率为9.43%,尚未发现严重术后并发症。结论:本新式阴道前壁补片修补术符合手术目的预期,具有微创化、经济、近期治愈率高和术后并发症率低等优势,但中远期治疗效果需继续随访。     

阴道前壁桥式缝合术修补阴道前壁脱垂32例临床观察

目的:探讨阴道前壁桥式缝合术治疗阴道前壁脱垂的疗效。方法:回顾性分析2007年8月至2008年12月,于我院住院手术治疗的阴道前壁脱垂60例患者的临床资料,其中阴道前壁桥式缝合术32例,传统的阴道前壁修补术28例,比较两种术式的近期疗效。结果:阴道前壁桥式缝合术的手术时间为12.50±3.10分钟,术中出血量为10.20±2.50ml,术后复发率为3.12%,与传统术式手术时间40.20±2.40分钟,术中出血量65.40±4.80ml,术后复发率25.00%比较,差异均有统计学意义(P<0.05)。结论:与传统术式比较,桥式缝合术治疗阴道前壁脱垂的手术时间短、术中出血少、术后复发率较低,近期疗效较满意。     

经阴道阴道旁修补术治疗阴道前壁膨出23例

目的:探讨经阴道阴道旁修补(VPVR)手术治疗阴道前壁膨出的临床疗效。方法:选自我院23例有临床症状的阴道前壁膨出患者行VPVR手术。术后3、6、9、12个月定期随访。结果:23例VPVR手术均获得成功,单计VPVR手术的平均时间为45分钟,平均术中出血量为110ml。术后平均随访7月(1~14月),仅有1例复发。主观治愈率100%,客观治愈率为95.7%。结论:采用经阴道阴道旁修补术是治疗阴道前壁膨出的一种安全有效的方法。     

前盆腔网片重建加阴道后壁桥式修补术治疗子宫脱垂的临床效果

目的:探讨聚丙烯网片前盆腔重建加阴道后壁修补术治疗中重度子宫脱垂的临床效果。方法:选取2010年1月至2013年1月在溧阳市人民医院和同济大学附属同济医院妇产科住院手术治疗的子宫脱垂患者共117例,术前POP-Q评分子宫脱垂Ⅲ~Ⅳ度。患者均采用自制聚丙烯网片前盆腔重建加阴道后壁桥式修补术,术后随访10~46个月,观察治疗效果及手术并发症。结果:117例患者的手术时间45~85min,术中出血量80~170ml。无1例膀胱、直肠损伤,1例于术后12个月复发,3例于术后2年后复发,9例(7.7%)患者术后有会阴部异物感和轻度疼痛,1例网片侵蚀。结论:聚丙烯网片前盆底重建加阴道后壁桥式修补术治疗子宫脱垂的效果良好,术后复发率低,手术并发症少。     

改良的阴道前壁膨出修补术60例临床效果观察

目的:探讨改良的阴道前壁膨出修补术的可行性和临床价值。方法:对60例阴道前壁膨出、阴道前后壁膨出或合并子宫脱垂患者进行改良的阴道前壁修补术,术后定期随访,对术后复发情况进行客观(临床检查)及主观(患者自觉症状或感觉)评价。结果:60例手术均获成功,术后随访6～18个月,仅有1例于术后12个月临床检查时发生轻度阴道前壁膨出,但患者主观上无自觉症状,无需再次手术。结论:改良的阴道前壁膨出修补术术后临床效果满意,复发率低。     

阴道前壁黏膜瓣悬吊治疗前盆腔器官脱垂52例疗效分析

目的 探讨阴道前壁黏膜瓣悬吊术治疗前盆腔器官脱垂的效果。 方法 回顾性分析郑州大学第二附属医院2005年1月至2010年1月间接受阴道前壁黏膜瓣悬吊术的52例前盆腔器官脱垂患者的临床资料。52例患者同时联合子宫切除术、附件切除术、阴道后壁修补术、骶棘韧带悬吊术、会阴陈旧性裂伤修补术和尿道中段悬吊术6种手术。 结果 52例行阴道前壁黏膜瓣悬吊术均获得成功。阴道前壁黏膜瓣悬吊平均手术时间为(43.5±5.2)min;平均出血量为(50.7±2.5)ml;无血肿发生,无尿道、膀胱及直肠损伤。术后有4例出现尿潴留,给予对症处理后,排尿功能恢复正常。52例术后随访12~60个月,平均随访28.2个月,患者无任何自觉症状,主观治愈率为100%,术后12~24个月复发5例( POP-Q分度法为Ⅰ度),客观治愈率为90.4%。 结论 阴道前壁黏膜瓣悬吊术配合其他缺陷修补的组合术式具有治愈率高,复发率低,无排斥反应,价格低廉,安全易行,近期疗效良好等特点。     

腹腔镜下子宫腹壁悬吊联合阴道前壁修补治疗子宫脱垂84例病例分析

目的:分析腹腔镜下子宫腹壁悬吊联合阴道前壁修补术治疗子宫脱垂的有效性及安全性。方法:选择2014年1月至2018年12月因Ⅲ~Ⅳ度子宫脱垂且合并阴道前壁膨出于溧阳市人民医院就诊的患者共84例,采用腹腔镜下简易子宫腹壁悬吊+阴道前壁修补进行治疗,伴有阴道后壁膨出的患者术中同时行阴道后壁桥式修补。术后随访12~72月(平均36.8月),记录患者术中情况、手术并发症及手术前后盆腔器官脱垂定量分度(POP-Q)及盆底功能影响问卷简表(PFIQ-7)评分。结果:腹腔镜下子宫腹壁悬吊+阴道前壁修补术的手术时间为(47.75±6.73)min,术中出血量(49.41±14.44)ml,无术中脏器损伤。术后1年随访客观治愈率97.6%(82/84),手术并发症发生率7.14%(6/84)。术后1年POP-Q评分中Aa、Ba、C、Ap、Bp各点的值均较术前有明显改善。患者术前PFIQ-7评分(116.29±17.97)分,术后6月评分(25.31±10.15)分,术后1年评分(26.32±7.85)分,差异有统计学意义(P<0.01)。结论:腹腔镜下简易子宫腹壁悬吊联合阴道前壁修补术治疗子宫脱垂操作简单,容易掌握,近期有效率高。     

两种前盆底重建术治疗阴道前壁脱垂临床疗效分析

<正>改良前盆底重建术是国内学者根据中国女性骨盆较小的特点,将10cm×15cm聚丙烯纤维网片修剪成"蜻蜓"形治疗阴道前壁脱垂,文献报道临床效果良好[1],我院将该术式用于临床,与同期开展的"梯形"网片前盆底重建术(阴道旁网片修补术)进行前瞻性比较,分析了手术安全性和临床应用价值。现     

Outcome after anterior vaginal prolapse repair: a randomized controlled trial

OBJECTIVES: To report 1-year outcomes of a randomized controlled trial comparing polypropylene mesh-reinforced anterior vaginal prolapse repair with anterior colporrhaphy. METHODS: Seventy-six patients with stage II or greater anterior vaginal prolapse were randomly assigned to either colporrhaphy or polypropylene mesh repair. The primary outcome was recurrent stage II anterior vaginal prolapse, and secondary outcomes were effects on quality of life and sexual symptom scores, operative time, blood loss, length of hospitalization, and adverse events. RESULTS: Thirty-eight women had anterior colporrhaphy, and 37 had polypropylene mesh repair. One patient allocated to mesh repair withdrew from the study before surgery. Clinical and demographic data did not differ significantly between the two treatment groups. One year after surgery, optimal and satisfactory anterior vaginal support were obtained in 21 of 38 (55%) of the colporrhaphy group and 33 of 38 (87%) of the mesh group (P=.005). Patients in both groups reported less bother after surgery in both prolapse and urinary symptoms. The rates of de novo dyspareunia were 4 of 26 (16%) and 2 of 23 (9%) in the colporrhaphy and mesh groups, respectively. Two of 37 (5%) patients had vaginal mesh extrusion. Nine anterior colporrhaphy patients would have to have recurrent anterior vaginal prolapse to prevent one vaginal mesh extrusion. Neither serious adverse events nor deaths occurred in either group. CONCLUSION: Anterior vaginal prolapse repair with polypropylene mesh reinforcement offers lower anatomic recurrence than anterior colporrhaphy at one year. However, quality of life and sexual symptoms scores improved in both groups.     

改良盆底重建术治疗盆腔器官脱垂的临床研究

目的:探讨改良盆底重建术治疗盆腔器官脱垂(POP)的临床实用性。方法:选取59例POP患者,其中19例采用改良盆底重建术(A组),20例采用阴式子宫全切除术+阴道前壁"斜拉桥"式修补术(B组);20例采用传统阴式子宫全切除术+阴道前壁修补术(C组)。比较3组患者的围手术期各项指标情况及术后复发、阴道深度、性生活保持情况及疼痛不适等并发症情况。结果:(1)3组患者的手术时间、术中出血量、术后病率、术后性生活保持率及术后随访主观复发率比较差异均无统计学意义(P0.05);3组的术后留置尿管时间及客观复发率两两比较差异均有统计学意义(P0.05),A组的留置尿管时间最短,C组的客观复发率较高。C组术后的平均阴道深度浅于A、B组,差异有统计学意义(P=0.000);但后两组比较差异无统计学意义。3组患者均无严重并发症发生。结论:3种术式均能短期内解决POP问题,改良盆底重建术术式简单易操作,可保持盆底结构及功能的完整性,短期内具有较好的疗效,但远期疗效尚待循证。     

Vaginal repair with mesh versus colporrhaphy for prolapse: a randomised controlled trial

Objective  To compare vaginal repair augmented by mesh with traditional colporrhaphy for the treatment of pelvic organ prolapse.
Design  Prospective randomised controlled trial.
Setting  Tertiary teaching hospital.
Population  One hundred and thirty-nine women with stage ≥2 prolapse according to the pelvic organ prolapse quantification (POP-Q) system requiring both anterior and posterior compartment repair.
Methods  Subjects were randomised to anterior and posterior vaginal repair with mesh augmentation (mesh group, n  = 69) or traditional anterior and posterior colporrhaphy (no mesh group, n  = 70).
Main outcome measures  The primary outcome was the absence of POP-Q stage ≥2 prolapse at 12 months. Secondary outcomes were symptoms, quality-of-life outcomes and satisfaction with surgery. Complications were also reported.
Results  For subjects attending the 12-month review, success in the mesh group was 81.0% (51 of 63 subjects) compared with 65.6% (40/61) in the no mesh group and was not significantly different ( P -value = 0.07). A high level of satisfaction with surgery and improvements in symptoms and quality-of-life data were observed at 12 months compared to baseline in both groups, but there was no significant difference in these outcomes between the two groups. Vaginal mesh exposure occurred in four women in the mesh group (5.6%). De novo dyspareunia was reported by five of 30 (16.7%) sexually active women in the mesh group and five of 33 (15.2%) in the no mesh group at 12 months.
Conclusion  In this study, vaginal surgery augmented by mesh did not result in significantly less recurrent prolapse than traditional colporrhaphy 12 months following surgery.     

Anatomical and functional assessment of anterior colporrhaphy versus polypropylene mesh surgery in cystocele treatment

Objective

To compare the anatomical and functional results of traditional anterior colporrhaphy and polypropylene mesh surgery in cystocele treatment.Study design: Prospective study conducted in the Urogynecology Clinic of Etlik Zubeyde Hanim Maternity and Women's Health Teaching and Research Hospital between June 2006 and February 2007. Forty patients with stage II and III cystocele according to the Pelvic Organ Prolapse Quantification system were allocated by a computer programme to conventional or mesh surgery. Twenty patients each underwent anterior colporrhaphy (group I) or polypropylene mesh (Sofradim^®, Parieten) surgery (group II). Both groups were followed for 12 months.

Results

At the end of the 12th month, anatomical cure rates were 15/20 (75%) and 19/20 (95%) in groups I and II, respectively, and the difference between the two groups was statistically significant (p < 0.05). De novo stress urinary incontinence developed in one patient in group I. Mesh erosion developed postoperatively in three cases (15%).

Conclusion

In terms of anatomical cure rates, polypropylene mesh surgery was the more successful treatment option when compared with anterior colporrhaphy at the end of 1 year follow-up.     

三种手术治疗重度盆腔器官脱垂的疗效观察及其复发因素分析

目的 比较"协和"全盆底重建手术、传统的阴式子宫全切除+阴道前后壁修补术、阴式子宫全切除+阴道前壁旁侧修补+骶棘韧带固定+阴道后壁"桥式"缝合+会阴修补术等3种手术治疗重度盆腔器官脱垂的疗效,探讨"协和"全盆底重建手术的临床应用价值.方法 选择重度盆腔器官脱垂,同时合并至少两个部位盆腔缺陷且需要手术的患者173例,86例(A组)采取植入聚丙烯网片材料,行"协和"全盆底重建手术,58例(B组)采取传统手术(阴式子宫全切除+阴道前后壁修补术),29例(C组)采取阴式子宫全切除+阴道前壁旁侧修补+骶棘韧带固定+阴道后壁"桥式"缝合+会阴修补术.比较术前、术中及术后情况,以问卷评分随访术后性生活及生命质量满意度,并分析复发影响因素.结果 (1)3组的手术时间、术中出血量、住院天数及术后病率,两两比较,差异均无统计学意义(P＞0.05).(2)住院费用:A组为(11448±3049)元,B组为(7262±1607)元,C组(7140±1817)元,A组明显多于B、C两组(P＜0.05).(3)术后阴道深度:A组[(7.5±1.4)cm]和C 组[(7.1±0.6)cm]长于B组[(5.6±1.1)cm],分别比较,差异均有统计学意义(P＜0.05).阴道宽度:A组[(4.3±0.3)cm]宽于B组[(3.4±0.3)cm]、C组[(3.3±0.4)cm],分别比较,差异均有统计学意义(P＜0.05).(4)术后12个月复发:A组的复发率12.8%(11/86)与C组的17.2%(5/29)相仿(P＞0.05),明显低于B组的36.2%(21/58),分别比较,差异均有统计学意义(P＜0.05).术后12个月内性生活保持率:A组为16.3%(14/86)明显高于B组的1.7%(1/58)和C组的0,分别比较,差异均有统计学意义(P＜0.05).术后12个月生命质量改善效果:A组[(48±12)分]与C组[(53±16)分]相当(P＞0.05),但均高于B组[(27±9)分],分别比较,差异均有统计学意义(P＜0.05).(5)A组6例网片排异均为阴道后壁,均发生于术后3个月内;B、C组无排异发生.术后新发尿潴留、尿失禁的发生率3组间比较,差异均无统计学意义(P＞0.05).(6)严重盆底功能障碍、传统手术方式、前盆腔缺陷、开展盆底重建手术的初期均为术后复发的高危因素(P均＜0.05).结论 "协和"全盆底重建手术保持了盆底解剖结构及功能完整性,具有疗效满意、术后复发率低、术后性生活及生命质量满意的特点;骶棘韧带固定+阴道前壁旁侧修补+阴道后壁"桥式"缝合+会阴修补术也有一定的疗效.

Abstract：

Objective To investigate clinical significance and application of modified pelvic floor reconstruction developed by Peking Union Medical College Hospital ( MPFR ) in treatment of severe pelvic organ prolapse (POP) by comparing the effectiveness, quality of postoperative sexual life, life satisfaction and risk factors for POP recurrence with the following two surgical procedures: traditional total vaginal hysterectomy with anterior-posterior colporrhaphy (TVH-APC) and total vaginal hysterectomy with lateral colporrhaphy and sacrospinous ligament fixation and vaginal bridge repair and episiotomy (TVH-LC-SSLFVBR-EP). Methods Totally 173 patients with severe POP and at least two compartments defects of pelvic floor underwent surgeries in the study, 86 patients (group A) were treated by MPFR with polypropylene mesh application, 58 (group B) were treated by TVH-APC, and 29 patients (group C) were treated by TVH-LC-SSLF-VBR-EP. Peri-operative data and outcomes of postoperative courses at 6, 12, 18 months were collected and analyzed, in the meantime, the risk factors of recurrence were studied. Results (1) No statistical difference was observed among the above 3 groups in terms of length of operation, amount of blood loss, length of hospital stay, and morbidity after surgery ( P ＞ 0.05). ( 2 ) Cost hospitalization was ( 11 448 ±3049) Yuan in group A, which was significantly higher than (7262 ± 1607) Yuan in group B and (7140 ± 1817 ) Yuan in group C (P ＜ 0.05 ). (3) The length of vaginal cuff of (7.5 ± 1.4) cm in group A and ( 5.6 ± 1.1 ) cm in group C were significantly longer than (7.1±0.6) cm in group B ( P＜0.05). The width of vaginal cuff of (4.3±0.3) cm in group A was larger than (3.4±0.3) cm in group B and (3.3±0.4) cm in group C (P＜0.05). (4) The recurrence rate at 12 months after surgery was 12.8% (11/86)in group A, which was similar with 17.2%(5/29) in group C (P＞0.05) and significantly less than 36.2% (21/58) in group B (P＜0.05). The rate of active sexual life of 16.3% (14/86) in group A was significantly higher than 1.7% (1/58) in group B and 0 in group C ( P ＜ 0. 05 ). The index of life quality improvement at 12 months after surgery was 48±12 in group A, which was no less than 53±16 in group C ( P＞0.05) and higher than 27 ± 9 in group B ( P＜0.05). (5 ) Mesh rejection was observed in 6 patients in group A within 3 months after surgery, while the posterior vaginal wall was exclusively involved. No difference was found in urinary retention or urinary incontinence among three groups (P ＞0. 05 ). (6) The severe degree of POP, type of surgical procedure ( TVT-APC), anterior compartment defect of pelvic floor,and early days of performing pelvic floor reconstruction surgeries were high risk factors for POP recurrence (P＜ 0.05). Conclusions MPFR has a better curative effect and lower recurrence rate on patients with POP. It can help patients regain integrity of anatomical structure and functions of pelvic floor. TVH-LCSSLF-VBR-EP is also effective.     

"协和"全盆底重建术治疗重度盆腔器官脱垂的多中心前瞻性研究

目的 探讨"协和"全盆底重建术治疗重度盆腔器官脱垂(POP)的疗效及对患者生命质量和性生活质量的影响.方法 自2006年6月至2008年12月,在全国8家医疗单位开展多中心前瞻性研究,包括北京协和医院、复旦大学附属妇产科医院、北京大学第一医院、北京大学第三医院、第三军医大学西南医院、四川大学华西第二医院、北京大学人民医院、北京妇产医院,共277例POP患者参加本研究,所有患者术前均为Ⅲ度或Ⅳ度.总结研究的中期结果,通过术后随访患者的POP分度情况了解POP的解剖学改善情况.通过比较患者术前、术后盆底功能影响问卷简表(PFIQ-7)和盆底不适调查表简表(PFDI-20)评分,评估手术对患者生命质量的影响;通过比较术前、术后POP-尿失禁性生活问卷(PISQ)评分,评价手术对患者性生活质量的影响.结果 中位随访时间14个月(6～28个月),23例患者术后复发,复发率为8.3%(23/277).19例(6.9%,19/277)患者在随访中发现网片暴露或侵蚀.术后新发的尿失禁为18例(6.5%,18/277).277例患者术前、术后6个月、术后1年的PFIQ-7评分分别为(66.9±65.1)、(7.2±26.7)、(7.6±31.6)分,PFDI-20评分分别为(75.8±49.0)、(17.4±25.2)、(15.0±22.6)分,术后较术前生命质量评分显著降低,差异均有统计学意义(P＜0.01).术前、术后6个月、术后1年的PSIQ评分分别为(76.6±15.4)、(75.5±14.5)、(73.6±12.6)分,术前与术后比较,差异无统计学意义(P＞0.05),手术对性生活质量无明显影响;但术后9例(11%,9/80)患者新发性交痛.结论 "协和"全盆底重建术是治疗重度POP一种有效、安全的手术,可以明显改善患者的生命质量,与传统的全盆底重建术疗效相当.

Abstract：

Objective To evaluate clinical efficiency and quality-of-life outcomes in treatment of severe pelvic organ prolapse by the "Xiehe" pelvic floor reconstruction surgery. Methods From Jun. 2006 to Dec. 2008, 277 severe pelvic organ prolapse patients with stage Ⅲ to Ⅳ from 8 hospitals in China were enrolled in this prospective study. Pelvic organ prolapse quantitative examination (POP-Q) and anatomic improvement in these patients after surgery were analyzed in this interim study. Comparisons of pelvic floor impact questionnaire-short form 7 (PFIQ-7) and pelvic floor distress inventory-short form 20 (PFDI-20) in these patients before and after surgery was used to evaluate quality of life. Comparison of pelvic organ prolapse-urinary incontinence sexual questionnaire (PISQ) in these patients before and after surgery was used to evaluate quality of sexual life. Results With a median follow-up of 14. 0 months (6 -28 months),twenty-three patients showed recurrent prolapse (8. 3%, 23/277), and anatomical success ( ＜ stage 2 in the treated compartment) was 91.7% (254/277). In this series, mesh exposure or erosion rate was 6. 9% (19/277). The postoperative de novo stress incontinence rate was 6. 5% (18/277). The scores for PFIQ-7 and PFDI-20, and its subscales were significantly improved, the scores of before treatment were lower than those after treatment (P ＜0. 01 ). And there was no significant difference in the average score of PISQ before and after the surgery (76. 6 ± 15.4 versus 75.5 ± 14. 5 versus 73.6 ± 12. 6, P ＞0. 05 ), but the rate of de novo dyspareunia was 11% (9/80). Conclusions "Xiehe" pelvic floor reconstruction surgery was safe and efficacy in treatment of pelvic organ prolapse. It could improve quality of life remarkably with less cost when compared with the traditional total pelvic floor reconstruction surgery.     

Changes in Female Sexual Function After Vaginal Mesh Repair Versus Native Tissue Repair for Pelvic Organ Prolapse: A Meta-Analysis of Randomized Controlled Trials

Aim

To evaluate changes in female sexual function after transvaginal mesh (TVM) repair versus native tissue repair for pelvic organ prolapse.

Transvaginal cystocele repair using tension-free polypropylene mesh at the time of sacrospinous colpopexy for advanced uterovaginal prolapse: a prospective randomised study

The management of an advanced multi-compartment prolapse requires a combination of techniques. The objective of this study was to report the anatomical outcomes of a prospective randomised trial comparing tension-free polypropylene mesh-reinforced anterior vaginal prolapse with anterior colporrhaphy at the time sacrospinous colpopexy and posterior fascial plication for the management of massive uterovaginal prolapse. A total of 116 patients with a stage III or IV (Pelvic Organ Prolapse Quantification System/International Continence Society) uterovaginal prolapse were randomised into two groups. The mesh group includes transvaginal cystocele repair using a tension-free polypropylene mesh, while the non-mesh group includes anterior colporrhaphy. All patients in the two groups underwent a sacrospinous colpopexy and posterior fascial plication. The primary outcome was objective success < stage 2 prolapse. The secondary outcomes were reoperation for recurrent prolapse, subjective success rates, patient satisfaction with the surgery and complications. The overall objective success rates (in all compartments) were 79 % (42/53) in the mesh group and 62 % (39/63) in the non-mesh group (p?=?0.043). The objective success rates in the anterior compartment were 85 % (45/53) in the mesh group and 62 % (39/63) in the non-mesh group (p?=?0.006). Three (6 %) patients in the mesh group and 12 (19 %) in the non-mesh group underwent repeat surgery for recurrent pelvic organ prolapse (p?=?0.03). The subjective success rates were 89 % (47/53) in the mesh group and 76 % (48/63) in the non-mesh group (p value?=?0.08). The mean patient satisfaction rates with the surgery were 84 % in the mesh group and 76 % in the non-mesh group (p?=?0.08). The development of a urinary tract infection, right-sided buttock pain (temporary sciatic neuralgia) and new-onset stress urinary incontinence were not significantly different between the two groups. The mesh exposure rate was 8 %. Transvaginal cystocele repair using tension-free polypropylene mesh at the time of sacrospinous colpopexy and posterior fascial plication offers lower anatomic recurrence and less need for further prolapse surgery to correct recurrent pelvic floor defects than anterior colporrhaphy, sacrospinous colpopexy and posterior fascial plication.     

Suburethral sling treatment of occult stress incontinence and intrinsic sphincter deficiency in women with severe vaginal prolapse of the anterior vs posterior/apical compartment

OBJECTIVE: The purpose of this study was to compare the efficacy of a Mersilene mesh suburethral sling for occult stress urinary incontinence (SUI) and intrinsic sphincter deficiency (ISD) in women with severe vaginal prolapse of the anterior compartment to the posterior/apical compartment. STUDY DESIGN: This was a retrospective study that compared women with stage or grade III/IV prolapse of the anterior compartment (group 1) with the posterior/apical compartment (group 2); both groups demonstrated occult SUI (leakage only with prolapse reduced) and ISD on urodynamics, and underwent concurrent pelvic reconstructive surgery. The sling was defined as efficacious if SUI was prevented in 85% of women and if obstructive symptoms (de novo or worsening urge incontinence, or urinary retention greater than 2 weeks) occurred in less than 10% of women. RESULTS: There were 39 women in group 1 and 25 women in group 2. There were no differences between women in group 1 or group 2 in preoperative demographics (except parity) or urodynamic findings. SUI cure rates were lower for group 1 than group 2, but this difference was not significant (87% vs 100%, P = .15). Rates of de novo or worsening urge incontinence (8% vs 4%, P = 1.00) and urinary retention (none occurred) were similar between groups. CONCLUSION: In women with severe vaginal prolapse, slings effectively treat occult SUI and ISD, whether associated with anterior or posterior/apical prolapse.